PolyPid logo

PolyPid

PYPD • NASDAQ • Stock Fundamentals

PolyPid is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dikla Czaczkes Akselbrad, with a market cap of $96.3M.

Market Cap$96.3M
Employees62.0
CEODikla Czaczkes Akselbrad
CountryIsrael
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026
View report
Next EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
PolyPid logo

PolyPid FAQ

Common questions about PolyPid

PolyPid (PYPD) has a market capitalization of $96.3M and trades on NASDAQ.

PolyPid has approximately 62 employees.